Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis.
about
Fexinidazole--a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sicknessChemotherapy for second-stage Human African trypanosomiasisNifurtimox plus Eflornithine for late-stage sleeping sickness in Uganda: a case seriesCardiac alterations in human African trypanosomiasis (T.b. gambiense) with respect to the disease stage and antiparasitic treatmentIdentification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaignThe death and life of the resurrection drugEstimates of the duration of the early and late stage of gambiense sleeping sicknessEliminating human African trypanosomiasis: where do we stand and what comes next?Difluoromethylornithine (DFMO) reduces deficits in isolation-induced ultrasonic vocalizations and balance following neonatal ethanol exposure in ratsCardiac involvement with parasitic infections.Human African trypanosomiasis in South Sudan: how can we prevent a new epidemic?In-hospital safety in field conditions of nifurtimox eflornithine combination therapy (NECT) for T. b. gambiense sleeping sickness.Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study.Whole-organism high-throughput screening against Trypanosoma brucei brucei.A method to improve the efficacy of topical eflornithine hydrochloride cream.From health advice to taboo: community perspectives on the treatment of sleeping sickness in the Democratic Republic of Congo, a qualitative study.A simple and sensitive assay for eflornithine quantification in rat brain using pre-column derivatization and UPLC-MS/MS detection.The molecular dynamics of Trypanosoma brucei UDP-galactose 4'-epimerase: a drug target for African sleeping sicknessPrevalence and under-detection of gambiense human African trypanosomiasis during mass screening sessions in Uganda and Sudan.Treatment options for second-stage gambiense human African trypanosomiasis.Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.Synthesis and assessment of catechol diether compounds as inhibitors of trypanosomal phosphodiesterase B1 (TbrPDEB1).Controlling sleeping sickness - a review.Trypanocidal drugs: mechanisms, resistance and new targets.Chemotherapy against human African trypanosomiasis: is there a road to success?Therapy of vector-borne protozoan infections in nonendemic settings.Human African trypanosomiasis in endemic populations and travellers.Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis.Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes.The Role of Natural Products in Drug Discovery and Development against Neglected Tropical Diseases.Computer-Aided Drug Design Using Sesquiterpene Lactones as Sources of New Structures with Potential Activity against Infectious Neglected Diseases.Nifurtimox-eflornithine combination therapy for second-stage gambiense human African trypanosomiasis: Médecins Sans Frontières experience in the Democratic Republic of the Congo.The blood-brain barrier significantly limits eflornithine entry into Trypanosoma brucei brucei infected mouse brain.Say what? The activity of the polyamine biosynthesis inhibitor difluoromethylornithine in chemoprevention is a result of reduced thymidine pools?African sleeping sickness.Future treatment options for human African trypanosomiasis.Chemotherapy of human african trypanosomiasis.The impact of passive case detection on the transmission dynamics of gambiense Human African Trypanosomiasis.Mortality trends and risk factors in advanced stage-2 Human African Trypanosomiasis: A critical appraisal of 23 years of experience in the Democratic Republic of Congo.
P2860
Q21144517-B2477955-50C4-4F45-939B-A60F92273B68Q24201785-BDFA04BB-E7BF-4C18-A717-D5E4C0CBD0F4Q28471706-937B6575-1BDF-4101-AAAF-2087F4D4666AQ28474798-1D8C868F-C6FF-4E38-9BA1-DE256039BC0EQ28485372-403C8569-27D8-4F43-93E7-FFF36F3E5B1FQ28540609-C33BF455-1C61-4947-B0A4-39D42E4D038CQ28755434-043EDDBE-1E04-47A1-ABBE-1DC59870EDA4Q33321396-3D57D6BA-065C-47E6-9F19-94AE7AD72F07Q33712640-8299C925-D871-46BD-B07B-FD4E9E448935Q33825602-98D311A1-D517-4C8C-A88A-7C5367D1EDD7Q34293008-E66985D3-8693-4DEC-A82B-F6F54D93EA31Q34500886-68C1A39E-DD46-45FE-9095-45391921106FQ34589130-4C3B93D0-A7B4-45F3-A4A9-E047A4CD6A3FQ34642037-EB082742-B6CE-47B0-BA63-57ADB2E2D531Q35143346-F6E52649-83B4-4238-8235-694CF785C74DQ35345427-92057D95-A6BB-4625-BB4C-A059472EF9FEQ35388587-F83B7856-3BFC-4E1E-AA29-A69D42F2365DQ36103511-D41A5978-0266-47A3-ABFF-7D89EB64ED37Q36198356-C4D01BD1-5BD1-494B-9FE3-4122D8033476Q36551049-5E836176-A731-4D7B-B6AA-1F43AC254A23Q36740553-CA9A221A-3E8A-41B4-83A8-F313CF392409Q37301306-B06B5CCC-4F85-4EEE-A5A5-F46FE2C6FD7FQ37582546-B9FB3117-1638-40E7-92AD-3715387F7489Q37623081-BB82A8FA-4306-45FA-8E0C-52CDAA0A5AB4Q37801690-96492028-DAF4-408D-A007-0F9C0D85D02BQ37879203-00AB2AB2-059D-43FC-A2FF-18F42F7E1DDEQ37929054-60DEFF2F-3C3D-40F8-A9A4-6D6E63B7E462Q37981773-29BF3675-4BC9-474C-8548-A4C23DB4E417Q38875419-36F3DD96-D0F4-406C-9F78-65AD17E34777Q38943630-1B3AFEAF-531E-43ED-9097-CFBC6C3CEA8BQ39065488-3D306550-3D55-45D7-9A66-52B4A279FF63Q39223286-1E7BBA20-A885-494E-BA3C-732BB42636B6Q41502922-4CBF9032-2295-4697-8399-68CA2775736CQ42085336-AAC2B539-004B-4CA9-BE10-C8C184953851Q43089194-E0417894-4207-4B26-9CFE-0F11B5AE0204Q48373153-522FD906-B591-4F36-A710-30887F8EC03BQ52595328-B3E2E727-BCCA-42C1-A10B-8358A10C80C2Q52602671-2935AD8F-A239-4B0F-B70D-FBE826F5AE33Q55322154-B044895E-85C6-4308-B4CB-C8E10ED1EC57
P2860
Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Eflornithine is safer than mel ...... human African trypanosomiasis.
@ast
Eflornithine is safer than mel ...... human African trypanosomiasis.
@en
type
label
Eflornithine is safer than mel ...... human African trypanosomiasis.
@ast
Eflornithine is safer than mel ...... human African trypanosomiasis.
@en
prefLabel
Eflornithine is safer than mel ...... human African trypanosomiasis.
@ast
Eflornithine is safer than mel ...... human African trypanosomiasis.
@en
P2093
P2860
P921
P356
P1476
Eflornithine is safer than mel ...... human African trypanosomiasis.
@en
P2093
Ann Meussen
Kai Stietenroth
Nitya Udayraj
Patrick A Bovier
P2860
P304
P356
10.1086/432576
P407
P577
2005-07-19T00:00:00Z